Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | FAP | Q12884 | 1/20 | 0.48 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 2/20 | 0.48 |
| ▸ | REN | P00797 | 1/20 | 0.48 |
| ▸ | XIAP | P98170 | 1/20 | 0.45 |
| ▸ | GRB2 | P62993 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29641766 | 0.91 | ACE (0.54) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL30844353 | 0.91 | CALCRL (0.46) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL30844271 | 0.89 | CALCRL (0.48) | XIAPGRB2F2 | |
| SCHEMBL29641611 | 0.88 | DPP4 (0.55) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL30585207 | 0.87 | CALCRL (0.46) | SLC6A2 | |
| SCHEMBL29630700 | 0.87 | GRB2 (0.44) | XIAPGRB2OPRM1OPRD1OPRK1 | |
| SCHEMBL31126288 | 0.87 | OPRM1 (0.42) | ACERENOPRM1OPRD1F2 | |
| SCHEMBL30974114 | 0.86 | CAPN1 (0.46) | XIAPGRB2OPRM1OPRD1OPRK1 | |
| SCHEMBL31696320 | 0.85 | CTSD (0.45) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL29470192 | 0.85 | ACE (0.50) | DPP4FAPDPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4654997-A1 | SARS-COV-2 VACCINE CONSTRUCTS | Rutgers, The State University of New Jersey (US) | 2025-12-03 | — | — | EP | claimed |
| US-20250345415-A1 | SARS-CoV-2 Vaccine Constructs | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-11-13 | — | — | US | claimed |
| WO-2024158722-A1 | SARS-COV-2 VACCINE CONSTRUCTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-08-02 | — | — | WO | claimed |
| EP-4654997-A1 | SARS-COV-2 VACCINE CONSTRUCTS | Rutgers, The State University of New Jersey (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250345415-A1 | SARS-CoV-2 Vaccine Constructs | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250304664-A1 | Human NTCP Binders For Therapeutic Use And Liver-Specific Targeted Delivery | VIB VZW (BE) | 2025-10-02 | — | — | US | disclosed |
| US-20250230197-A1 | MALARIA VACCINE | UNIV OXFORD INNOVATION LTD (GB) | 2025-07-17 | — | — | US | disclosed |
| EP-4463479-A1 | HUMAN NTCP BINDERS FOR THERAPEUTIC USE AND LIVER-SPECIFIC TARGETED DELIVERY | VIB VZW (BE) | 2024-11-20 | — | — | EP | disclosed |
| WO-2024158722-A1 | SARS-COV-2 VACCINE CONSTRUCTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-08-02 | — | — | WO | disclosed |
| WO-2023135198-A1 | HUMAN NTCP BINDERS FOR THERAPEUTIC USE AND LIVER-SPECIFIC TARGETED DELIVERY | VIB VZW (BE) | 2023-07-20 | — | — | WO | disclosed |
| US-20220411495-A1 | POSITIVE ALLOSTERIC MODULATORS OF THE CALCIUM-SENSING RECEPTOR | UNIVERSITY OF COPENHAGEN (DK) | 2022-12-29 | — | — | US | disclosed |
| EP-4065603-A1 | POSITIVE ALLOSTERIC MODULATORS OF THE CALCIUM-SENSING RECEPTOR | VIB VZW (BE) | 2022-10-05 | — | — | EP | disclosed |